Antiepileptic drugs and apoptotic neurodegeneration in the developing brain

被引:587
作者
Bittigau, P
Sifringer, M
Genz, K
Reith, E
Pospischil, D
Govindarajalu, S
Dzietko, M
Pesditschek, S
Mai, I
Dikranian, K
Olney, JW
Ikonomidou, C
机构
[1] Humboldt Univ, Charite, Childrens Hosp,Virchow Clin, Dept Pediat Neurol, D-13353 Berlin, Germany
[2] Humboldt Univ, Dept Clin Pharmacol, D-10117 Berlin, Germany
[3] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
关键词
survival; epilepsy; rat; neurotrophins;
D O I
10.1073/pnas.222550499
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Epilepsy is the most common neurological disorder of young humans. Each year 150,000 children in the United States experience their first seizure. Antiepileptic drugs (AEDs), used to treat seizures in children, infants, and pregnant women, cause cognitive impairment, microcephaly, and birth defects. The cause of unwanted effects of therapy with AEDs is unknown. Here we reveal that phenytoin, phenobarbital, diazepam, clonazepam, vigabatrin, and valproate cause apoptotic neurodegeneration in the developing rat brain at plasma concentrations relevant for seizure control in humans. Neuronal death is associated with reduced expression of neurotrophins and decreased concentrations of survival-promoting proteins in the brain. beta-Estradiol, which stimulates pathways that are activated by neurotrophins, ameliorates AED-induced apoptotic neurodegeneration. Our findings present one possible mechanism to explain cognitive impairment and reduced brain mass associated with prenatal or postnatal exposure of humans to antiepileptic therapy.
引用
收藏
页码:15089 / 15094
页数:6
相关论文
共 39 条
  • [1] Neuroprotective activities of estrogen: An update
    Behl, C
    Manthey, D
    [J]. JOURNAL OF NEUROCYTOLOGY, 2000, 29 (5-6): : 351 - 358
  • [2] Drug therapy - Antiepileptic drugs
    Brodie, MJ
    Dichter, MA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) : 168 - 175
  • [3] PRENATAL PREDICTION OF RISK OF THE FETAL HYDANTOIN SYNDROME
    BUEHLER, BA
    DELIMONT, D
    VANWAES, M
    FINNELL, RH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (22) : 1567 - 1572
  • [4] Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin
    Dalby, NO
    Nielsen, EB
    [J]. EPILEPSY RESEARCH, 1997, 28 (01) : 63 - 72
  • [5] IMPROVED CUPRIC-SILVER METHOD FOR IMPREGNATION OF AXONAL AND TERMINAL DEGENERATION
    DEOLMOS, JS
    INGRAM, WR
    [J]. BRAIN RESEARCH, 1971, 33 (02) : 523 - &
  • [6] Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats
    DeSarro, G
    DiPaola, ED
    Aguglia, U
    deSarro, A
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 55 (01) : 39 - 48
  • [7] Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems
    Dessens, AB
    Cohen-Kettenis, PT
    Mellenbergh, GJ
    Koppe, JG
    van de Poll, NE
    Boer, K
    [J]. ACTA PAEDIATRICA, 2000, 89 (05) : 533 - 541
  • [8] COMPARATIVE ASPECTS OF THE BRAIN GROWTH SPURT
    DOBBING, J
    SANDS, J
    [J]. EARLY HUMAN DEVELOPMENT, 1979, 3 (01) : 79 - 83
  • [9] PHENOBARBITAL FOR FEBRILE SEIZURES - EFFECTS ON INTELLIGENCE AND ON SEIZURE RECURRENCE
    FARWELL, JR
    LEE, YJ
    HIRTZ, DG
    SULZBACHER, SI
    ELLENBERG, JH
    NELSON, KB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (06) : 364 - 369
  • [10] Vigabatrin: A novel therapy for seizure disorders
    Gidal, BE
    Privitera, MD
    Sheth, RD
    Gilman, JT
    [J]. ANNALS OF PHARMACOTHERAPY, 1999, 33 (12) : 1277 - 1286